Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: Doctor

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Moreno, S; Maiques, O; Gatius, S; Vea, A; Barrera, J; Barcelo, C; Santacana, M; Soria, X; Matias-Guiu, X; Marti, RM

    Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 1210-1217. .

    [doi:10.1111/jdv.16084]

  • Reijnen, C; Gogou, E; Visser NCM; Engerud, H; Ramjith, J; van der Putten LJM; van de Vijver K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Reques, A; Mancebo, G; Krakstad, C; Trovik, J; Haldorsen, IS; Huvila, J; Koskas, M; Weinberger, V; Bednarikova, M; Hausnerova, J; van der Wurff AAM; Matias-Guiu, X; Amant, F; ENITEC Consortium; Massuger LFAG; Snijders MPLM; Küsters-Vandevelde HVN; Lucas PJF; Pijnenborg JMA

    Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study.

    PLOS MEDICINE 17 e1003111-. .

    [doi:10.1371/journal.pmed.1003111]

  • Delgado-Garcia, M; Weynand, B; Gomez-Izquierdo, L; Hernandez, MJ; Blanco, AM; Varela, M; Matias-Guiu, X; Nadal, E; Marquez-Lobo, B; Alarcão A; de Alava, E; Biscuola, M

    Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.

    Bmc Cancer 20 275-275. .

    [doi:10.1186/s12885-020-6697-7]

  • Matias-Guiu, X; Stanta, G; Carneiro, F; Ryska, A; Hoefler, G; Moch, H; European Society of Pathology (ESP)

    The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.

    VIRCHOWS ARCHIV 476 491-497. .

    [doi:10.1007/s00428-020-02757-0]

  • Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Zudaire, T; Guarch, R; Guerrero-Setas, D; Vidal, A; Santos-Salas, J; Matias-Guiu, X; Ausin, K; Díaz de Cerio MJ; Martin-Sanchez, E

    Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 2125-. .

    [doi:10.3390/ijms21062125]

  • Leon-Castillo, A; Gilvazquez, E; Nout, R; Smit, VTHBM; McAlpine, JN; McConechy, M; Kommoss, S; Brucker, SY; Carlson, JW; Epstein, E; Rau, TT; Soslow, RA; Ganesan, R; Matias-Guiu, X; Oliva, E; Harrison, BT; Church, DN; Gilks, CB; Bosse, T

    Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas

    JOURNAL OF PATHOLOGY 250 312-322. .

    [doi:10.1002/path.5373]

  • Santiago-O'Farrill, JM; Weroha, SJ; Hou, XN; Oberg, AL; Heinzen, EP; Maurer, MJ; Pang, L; Rask, P; Amaravadi, RK; Becker, SE; Romero, I; Rubio, MJ; Matias-Guiu, X; Santacana, M; Llombart-Cussac, A; Poveda, A; Lu, Z; Bast, RC

    Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.

    CANCER 126 894-907. .

    [doi:10.1002/cncr.32600]

  • Cuevas, D; Velasco, A; Vaquero, M; Santacana, M; Gatius, S; Eritja, N; Estaran, E; Matias-Guiu, X

    Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY.

    Histopathology 76 447-460. .

    [doi:10.1111/his.14001]

  • Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A

    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .

    [doi:10.1016/j.jid.2019.11.014]

  • Davidson, B; Matias-Guiu, X; Lax, SF

    The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma.

    VIRCHOWS ARCHIV 476 489-490. .

    [doi:10.1007/s00428-020-02762-3]

  • Cameselle-Teijeiro JM; Bella Cueto MR; Eloy C; Abdulkader I; Amendoeira I; Matías-Guiu X; Sobrinho-Simões M

    Tumores de la glándula tiroides. Propuesta para el manejo y estudio de las muestras de pacientes con neoplasias tiroideas.

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 53 27-36. .

    [doi:10.1016/j.patol.2019.03.003]

  • Etxeberria, I; Bolaños E; Quetglas, JI; Gros, A; Villanueva, A; Palomero, J; Sanchez-Paulete, AR; Piulats, JM; Matias-Guiu, X; Olivera, I; Ochoa, MC; Labiano, S; Garasa, S; Rodriguez, I; Vidal, A; Mancheño U; Hervas-Stubbs, S; Azpilikueta, A; Otano, I; Aznar, MA; Sanmamed, MF; Inoges, S; Berraondo, P; Teijeira, A; Melero, I

    Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8(+)T Cells

    CANCER CELL 36 613-. .

    [doi:10.1016/j.ccell.2019.10.006]

Projects

  • Plataforma de Biobancos y Biomodelos
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • Plataforma Red Nacional de Biobancos
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Ajut per donar suport a les activitats del grup de recerca consolidat de càncer ginecològic i afins
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • Grup de Càncer
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU